NCT03092206View on ClinicalTrials.gov

Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 18, 2017

Primary Completion Date

July 28, 2017

Study Completion Date

July 28, 2017

Conditions
Insulin Resistance
Interventions
DRUG

F/TAF

antiretroviral therapy

DRUG

E/C/F/TAF

antiretroviral therapy

DRUG

R/F/TAF

antiretroviral therapy

Trial Locations (1)

81675

Klinikum rechts der Isar (IZAR), Munich

All Listed Sponsors
lead

Technical University of Munich

OTHER

NCT03092206 - Changes in Insulin Sensitivity in Healthy Volunteers Taking Tenofovir Alafenamide (TAF)-Containing Antiretroviral Medication | Biotech Hunter | Biotech Hunter